Contraceptives Market size was valued at USD 1.30 billion in 2023 and is expected to reach at USD 6.10 billion by 2031, and grow at a CAGR of 21.20% over the forecast period of 2024-2031.
The contraception method is basically used to prevent pregnancy using drugs or a device. The rise in the focus regarding the family planning and prevention against unwanted pregnancy is the driving factor for the contraceptives market. The rise in the young women abortion is also the rising factor for the contraceptive market. Also, that these days working women don’t want child at their early age so contraceptives method can be used, this are the driving factor for the contraceptive market. Also, the government initiatives taken by the government for the benefit of the women health is propelling the market.
Get more information on Contraceptives Market - Request Sample Report
Covid 19 had a negative impact on the contraceptives market, due to the stop in the production of the contraceptive drugs also the demand dropped during the covid 19 which resulted in the negative impact on the contraceptive market.
Market Dynamics.
Drivers
Rise in the awareness of the contraceptive products all around the globe.
Increase in the abortion rate.
Restrain
Lack of social acceptance in the emerging countries.
Opportunities
Rise in the government initiatives to prevent unwanted pregnancies.
Challenges
The cases of side effects due to the consumption of contraceptives medicines.
Impact of Russia Ukraine war didn’t have that much of impact on the contraceptive market, but the major factors which got affected because of the war was the disruption of supply chain and the global disturbance.
Impact of ongoing recession
This report will give you an overview about how the recession has impacted the contraceptive market as the recession will change the perception of the people also the buying pattern of the people will change.
Market segmentation analysis
Contraceptive market is divided into three types by product type by age group and by end user the product type drugs and devices, by age group includes 15-44 and above 44 and the end user includes household for their personnel use and the hospitals and clinics for their patients.
By Product Type:
Drugs
Devices
By Age Group:
15-44
Above 44
By End User:
Households
Hospitals
Clinics
Get Customized Report as per your Business Requirement - Request For Customized Report
North America is expected to share the highest market share due to the increase in the awareness among the people living in that region, also the government initiative regarding women’s health is also the driving factor of the contraceptive market.
By Region:
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
The major key players are Bayer Ag, Pfizer, Inc, Cooper Companies, Ansell Ltd, Mayer Laboratories, Merck &CO, Church & Dwight, Vera.
| Report Attributes | Details |
| Market Size in 2023 | US$ 1.30 Bn |
| Market Size by 2031 | US$ 6.10 Bn |
| CAGR | CAGR of 21.20% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (drugs, devices) • By Age Group (15-44, above44) • By End User (Households, Hospitals, Clinics) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Bayer Ag, Pfizer, Inc, Cooper Companies, Ansell Ltd, Mayer Laboratories, Merck &CO, Church & Dwight, Vera. |
| Key Drivers | • Rise in the awareness of the contraceptive products all around the globe. • Increase in the abortion rate. |
| Market Opportunities | • Rise in the government initiatives to prevent unwanted pregnancies. |
Contraceptives Market size was valued at USD 1.08 billion in 2022.
Contraceptive market is expected to reach at USD 4.96 billion by 2030
The cases of side effects due to the consumption of contraceptives medicines.
Rise in the government initiatives to prevent unwanted pregnancies.
Contraceptive market is divided into three types by product type by age group and by end user.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of the Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Contraceptives Market Segmentation, by productivity Type
8.1 Drugs
8.2 Devices
9. Contraceptives Market Segmentation, by age group
9.1 15-44
9.2 Above 44
10. Contraceptives Market Segmentation, by End User
10.1 Households
10.2 Hospitals
10.3 Clinics
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.1.1 USA Contraceptives Market by Connectivity Type
11.2.1.2 USA Contraceptives Market by Resolutions
11.2.1.3 USA Contraceptives Market by Verticals
11.2.2 Canada
11.2.2.1 Canada Contraceptives Market by Connectivity Type
11.2.2.2 Canada Contraceptives Market by Resolutions
11.2.2.3 Canada Contraceptives Market by Verticals
11.2.3 Mexico
11.2.3.1 Mexico Contraceptives Market by Connectivity Type
11.2.3.2 Mexico Contraceptives Market by Resolutions
11.2.3.3 Mexico Contraceptives Market by Verticals
11.3 Europe
11.3.1 Germany
11.3.1.1 Germany Contraceptives Market by Connectivity Type
11.3.1.2 Germany Contraceptives Market by Resolutions
11.3.1.2 Germany Contraceptives Market by Verticals
11.3.2 UK
11.3.2.1 UK Contraceptives Market by Connectivity Type
11.3.2.2 UK Contraceptives Market by Resolutions
11.3.2.3 UK Contraceptives Market by Verticals
11.3.3 France
11.3.3.1 France Contraceptives Market by Connectivity Type
11.3.3.2 France Contraceptives Market by Resolutions
11.3.3.3 France Contraceptives Market by Verticals
11.3.4 Italy
11.3.4.1 Italy Contraceptives Market by Connectivity Type
11.3.4.2 Italy Contraceptives Market by Resolutions
11.3.4.3 Italy Contraceptives Market by Verticals
11.3.5 Spain
11.3.5.1 Spain Contraceptives Market by Connectivity Type
11.3.5.2 Spain Contraceptives Market by Resolutions
11.3.5.3 Spain Contraceptives Market by Verticals
11.3.6 The Netherlands
11.3.6.1 Netherlands Contraceptives Market by Connectivity Type
11.3.6.2 Netherlands Contraceptives Market by Resolutions
11.3.6.3 Netherlands Contraceptives Market by Verticals
11.3.7 Rest of Europe
11.3.7.1 Rest of Europe Contraceptives Market by Connectivity Type
11.3.7.2 Rest of Europe Contraceptives Market by Resolutions
11.3.7.3 Rest of Europe Contraceptives Market by Verticals
11.4 Asia-Pacific
11.4.1 Japan
11.4.1.1 Japan Contraceptives Market by Connectivity Type
11.4.1.2 Japan Contraceptives Market by Resolutions
11.4.1.3 Japan Contraceptives Market by Verticals
11.4.2 South Korea
11.4.2.1 South Korea Contraceptives Market by Connectivity Type
11.4.2.2 South Korea Contraceptives Market by Resolutions
11.4.2.3 South Korea Contraceptives Market by Verticals
11.4.3 China
11.4.3.1 China Contraceptives Market by Connectivity Type
11.4.3.2 China Contraceptives Market by Resolutions
11.4.3.3 China Contraceptives Market by Verticals
11.4.4 India
11.4.4.1 India Contraceptives Market by Connectivity Type
11.4.4.2 India Contraceptives Market by Resolutions
11.5.4.3 India Contraceptives Market by Verticals
11.4.5 Australia
11.4.5.1 Australia Contraceptives Market by Connectivity Type
11.4.5.2 Australia Contraceptives Market by Resolutions
11.4.5.3 Australia Contraceptives Market by Verticals
11.4.6 Rest of Asia-Pacific
11.4.6.1 APAC Contraceptives Market by Connectivity Type
11.4.6.2 APAC Contraceptives Market by Resolutions
11.4.6.3 APAC Contraceptives Market by Verticals
11.5 The Middle East & Africa
11.5.1 Israel
11.5.1.1 Israel Contraceptives Market by Connectivity Type
11.5.1.2 Israel Contraceptives Market by Resolutions
11.5.1.3 Israel Contraceptives Market by Verticals
11.5.2 UAE
11.5.2.1 UAE Contraceptives Market by Connectivity Type
11.5.2.2 UAE Contraceptives Market by Resolutions
11.5.2.3 UAE Contraceptives Market by Verticals
11.5.3 South Africa
11.5.3.1 South Africa Contraceptives Market by Connectivity Type
11.5.3.2 South Africa Contraceptives Market by Resolutions
11.5.3.3 South Africa Contraceptives Market by Verticals
11.5.4 Rest of Middle East & Africa
11.5.4.1 Rest of Middle East & Asia Contraceptives Market by Connectivity Type
11.5.4.2 Rest of Middle East & Asia Contraceptives Market by Resolutions
11.5.4.3 Rest of Middle East & Asia Contraceptives Market by Verticals
11.6 Latin America
11.6.1 Brazil
11.6.1.1 Brazil Contraceptives Market by Connectivity Type
11.6.1.2 Brazil Africa Contraceptives Market by Resolutions
11.6.1.3 Brazil Contraceptives Market by Verticals
11.6.2 Argentina
11.6.2.1 Argentina Contraceptives Market by Connectivity Type
11.6.2.2 Argentina Contraceptives Market by Resolutions
11.6.2.3 Argentina Contraceptives Market by Verticals
11.6.3 Rest of Latin America
11.6.3.1 Rest of Latin America Contraceptives Market by Connectivity Type
11.6.3.2 Rest of Latin America Contraceptives Market by Resolutions
11.6.3.3 Rest of Latin America Contraceptives Market by Verticals
12. Company Profile
12.1 Bayer Ag
12.1.1 Market Overview
12.1.2 Financials
12.1.3 Product/Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Pfizer,
12.2.1 Market Overview
12.2.2 Financials
12.2.3 Product/Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Cooper Companies
12.3.1 Market Overview
12.3.2 Financials
12.3.3 Product/Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Ansell Ltd
12.4.1 Market Overview
12.4.2 Financials
12.4.3 Product/Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5, Mayer Laboratories
12.5.1 Market Overview
12.5.2 Financials
12.5.3 Product/Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Merck &CO
12.6.1 Market Overview
12.6.2 Financials
12.6.3 Product/Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Church & Dwight.
12.7.1 Market Overview
12.7.2 Financials
12.7.3 Product/Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Veru
12.8.1 Market Overview
12.8.2 Financials
12.8.3 Product/Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share analysis
13.3 Recent Developments
14. Use Cases And Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Human Insulin Market size was valued at USD 19.21 billion in 2023 and is expected to reach USD 24.71 billion by 2031 and grow at a CAGR of 3.2% over the forecast period of 2024-2031.
The Central Nervous System Treatment Market size was valued at USD 97.20 Bn in 2022 and is expected to reach USD 196.53 Bn by 2030 and grow at a CAGR of 9.2% over the forecast period of 2023-2030.
The Urgent Care Apps Market Size was valued at USD 1236 million in 2022 and is expected to reach USD 2254 million by 2030 and grow at a CAGR of 7.8% over the forecast period 2023-2030.
The Healthcare Virtual Assistants Market size was valued at USD 957.61 million in 2022 and is projected to reach USD 10.44 billion with a growing CAGR of 34.8% over the forecast period 2023-2030.
The Medical Tourism Market size was valued at USD 12.16 billion in 2023 and is expected to reach at USD 74.37 billion by 2031 and grow at a CAGR of 25.40% over the forecast period of 2024-2031.
The Respiratory Syncytial Virus (RSV) Therapeutics Market size was USD 1040.65 Million in 2022 and is expected to Reach USD 9080.84 Million by 2030 and grow at a CAGR of 31.1% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
